Our offerings
Market Access Strategy, HTA, and Health Economics
Nordic RWE & Evidence Generation
AI & Dashboard Solutions
Policy Shaping & Life Science Consulting
Our work
The latest
Our people
Careers
Contact us
Breaking: Denmark speeds up access to PD-(L)1 immunotherapies
Danish Medicines Council declines vamorolone for Duchenne
Janus Laust Thomsen joins Denmark’s medicines council
Danish Medicines Council appraised 84 new medicines in 2025
Denosumab biosimilars: Danish council urges cheapest choice
Medicinrådet launches real-world data pilots in oncology
Region Midtjylland appoints new member to Medicinrådet
Previous
1
2
Menu
